1Department of Neurodegenerative Diseases, Parke-Davis Pharmaceutical Research Division of the Warner-Lambert Company, Ann Arbor, MI 48106-1047, USA.
Beta(1-40) peptide forms soluble pentameric/hexameric complexes that aggregate into amyloid structures under specific conditions. This cooperative growth mechanism may explain plaque accretion and neurotoxicity variations.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: